Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

Fosfomycin: A Novel Epoxide Antimicrobial

OCT 12, 2017 | CONTAGION® EDITORIAL STAFF


Evelyn J. Ellis-Grosse, PhD, chief scientific officer of Zavante Therapeutics, explains why Zavante Therapeutic’s fosfomycin is a novel antimicrobial. She also shares what the drug’s unique mechanism of action is.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
Despite clearing the virus, researchers find that Ebola survivors can suffer long-term effects of infection.
x